Previous 10 | Next 10 |
PainReform Ltd. (NASDAQ:PRFX) traded at a new 52-week low today of $3.16. So far today approximately 500,000 shares have been exchanged, as compared to an average 30-day volume of 136,000 shares. PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the re...
Shares of PainReform Ltd. (NASDAQ:PRFX) traded today at $3.09, breaking its 52-week low. Approximately 500,000 shares have changed hands today, as compared to an average 30-day volume of 136,000 shares. Potential upside of 40.2% exists for PainReform Ltd., based on a current level of $3....
PainReform Ltd. (NASDAQ:PRFX) traded at a new 52-week low today of $3.70. This new low was reached on above average trading volume as 500,000 shares traded hands, while the average 30-day volume is approximately 136,000 shares. PainReform Ltd. has overhead space with shares priced $3.89,...
Shares of PainReform Ltd. (NASDAQ:PRFX) traded today at $3.61, breaking its 52-week low. This new low was reached on above average trading volume as 500,000 shares traded hands, while the average 30-day volume is approximately 136,000 shares. In the past 52 weeks, shares of PainReform Lt...
Gainers: Clovis Oncology (CLVS) +43%, Marker Therapeutics (MRKR) +23%, Alector (ALEC) +17%, Aravive (ARAV) +14%, Ortho Clinical Diagnostics (OCDX) +8%.Losers: Idera Pharmaceuticals (IDRA) -62%, Praxis Precision Medicines (PRAX) -13%, Acu...
HERZLIYA, Israel, March 18, 2021 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company”), a clinical stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today provided a year-end busi...
PainReform ([[PRFX]] +3.6%) entered into securities purchase agreements with certain institutional investors to raise ~$6M through the private placement of 1.3M shares and accompanying warrants to purchase 652,173 shares at a combined purchase price of $4.60/share and accompanying ...
HERZLIYA, Israel, March 08, 2021 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company”), a clinical stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced that it has entered in...
HERZLIYA, Israel, Jan. 07, 2021 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company”), a clinical stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced that it will be present...
HERZLIYA, Israel, Jan. 06, 2021 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company”), a clinical stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced the appointment of Rita...
News, Short Squeeze, Breakout and More Instantly...
TEL AVIV, Israel, July 24, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd . (Nasdaq: PRFX) (" PainReform " or the " Company "), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced it has filed a patent coveri...
TEL AVIV, Israel, June 26, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd . (Nasdaq: PRFX) (" PainReform " or the " Company "), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced a major milestone on the way to regi...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) rose 3.5% to $129.61 on volume of 255,610,868 shares Longeveron Inc. (LGVN) rose 48.6% to $2.69 on volume of 190,987,878 shares PROSHARES TRUST (SQQQ) fell 1.6% to $8.54 on volume of 116,711,722 shares Tesl...